In the latest legal battle over abortion access, federal judges in Texas and Washington have issued opinions at odds with one another over the Food and Drug Administration's approval of the abortion pill Mifepristone. Medication abortions accounted for 54% of abortions in the U.S. in 2020, according to the Guttmacher Institute.

WSJ’s Laura Kusisto breaks down the rulings, what they mean for abortion access across the country and the implications for the drug approval process moving forward.

0:00 Abortion pill Mifepristone is at the center of the latest legal battle
0:33 What the rulings in Texas and Washington mean for abortion access in the U.S.
1:54 What this could mean for the FDA's drug approval process
2:30 What’s next?

News Explainers
Some days the high-speed news cycle can bring more questions than answers. WSJ’s news explainers break down the day's biggest stories into bite-size pieces to help you make sense of the news.

#Abortion #Mifepristone #WSJ

свернуть